Niclosamide exerts anticancer effects through inhibition of the FOXM1-mediated DNA damage response in prostate cancer

Niclosamide, an established anti-helminthic drug, has anticancer activity against various cancers including prostate cancer, but the underlying mechanisms have not yet been defined. We demonstrated the anticancer effects of niclosamide in castration-resistant prostate cancer (CRPC) cells, and elucid...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Cancer Res
Hlavní autoři: Kim, Mee Young, Jung, Ae Ryang, Shin, Dongho, Kwon, Hyeokjae, Cho, Hyuk Jin, Ha, U-Syn, Hong, Sung-Hoo, Lee, Ji Youl, Kim, Sae Woong, Park, Yong Hyun
Médium: Artigo
Jazyk:Inglês
Vydáno: e-Century Publishing Corporation 2021
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8263667/
https://ncbi.nlm.nih.gov/pubmed/34249437
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky